Matthias Lutz

2.3k total citations
66 papers, 1.1k citations indexed

About

Matthias Lutz is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matthias Lutz has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matthias Lutz's work include Coronary Interventions and Diagnostics (19 papers), Cardiac Valve Diseases and Treatments (15 papers) and Cardiac Imaging and Diagnostics (7 papers). Matthias Lutz is often cited by papers focused on Coronary Interventions and Diagnostics (19 papers), Cardiac Valve Diseases and Treatments (15 papers) and Cardiac Imaging and Diagnostics (7 papers). Matthias Lutz collaborates with scholars based in Germany, France and Brazil. Matthias Lutz's co-authors include Norbert Frey, Hugo A. Katus, Derk Frank, Christian Schlegel, Tom Luedde, Hans‐Joerg Hippe, Mark Luedde, Christoph Roderburg, D. Stampfer and Ulrich Flögel and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Matthias Lutz

62 papers receiving 1.1k citations

Peers

Countries citing papers authored by Matthias Lutz

Since Specialization

Citations

This map shows the geographic impact of Matthias Lutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Lutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Lutz more than expected).

Fields of papers citing papers by Matthias Lutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Lutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Lutz. The network helps show where Matthias Lutz may publish in the future.

Co-authorship network of co-authors of Matthias Lutz

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Lutz. A scholar is included among the top collaborators of Matthias Lutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Lutz. Matthias Lutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Miniature Dual-Fiber Probe for Quantitative Optical Coherence Elastography 2023 ·IEEE Transactions on Biomedical Engineering ·(unknown), (unknown), (unknown), (unknown), Stefan Gerlach, (unknown), Gereon Hüttmann, Matthias Lutz, Alexander Schlaefer	5
2	Is the outcome of elective vs non-elective patients undergoing transcatheter aortic valve implantation different? Results of a single-centre, observational assessment of outcomes at a large university clinic 2023 ·BMC Cardiovascular Disorders ·(unknown), (unknown), (unknown), (unknown), (unknown), Thomas Puehler, Georg Lutter, Matthias Lutz, Mohammed Saad, Peter Bramlage, Janarthanan Sathananthan, David Wood, Sandra Lauck, Norbert Frey, Derk Frank	0
3	HFA-PEFF Score: Prognosis in Patients with Preserved Ejection Fraction After Transcatheter Aortic Valve Implantation 2022 ·ESC Heart Failure ·(unknown), (unknown), (unknown), (unknown), Thomas Puehler, Georg Lutter, Matthias Lutz, Peter Bramlage, Norbert Frey, Mohammed Saad, Derk Frank	14
4	TCT-46 FANTOM II Trial: Safety and Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold: First Report on Initial 48-Month Outcomes 2019 ·Journal of the American College of Cardiology ·Alexandre Abizaid, Matthias Lutz, Dariusz Dudek, (unknown)	1
5	Clinical and Angiographic Outcomes With a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold 2019 ·Circulation Cardiovascular Interventions ·Bernard Chevalier, Alexandre Abizaid, Didier Carrié, Norbert Frey, Matthias Lutz, (unknown), Darius Dudek, (unknown), Mariama Akodad, Jeffrey Anderson, Gregg W. Stone	24
6	TCT-332 FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 24 Month Outcomes 2017 ·Journal of the American College of Cardiology ·Alexandre Abizaid, (unknown), Norbert Frey, Matthias Lutz, (unknown), Darius Dudek, Bernard Chevalier, Alexandra J. Lansky, Jeffrey Anderson	3
7	6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold 2017 ·JACC: Cardiovascular Interventions ·Alexandre Abizaid, Didier Carrié, Norbert Frey, Matthias Lutz, (unknown), Darius Dudek, Bernard Chevalier, (unknown), Ricardo A. Costa, Jeffrey Anderson, Gregg W. Stone	43
8	TCT-29 Performance and healing patterns after implantation of a novel sirolimus eluting bioresorbable scaffold. Six-month follow-up by optical coherence tomography in the FANTOM II study 2016 ·Journal of the American College of Cardiology ·(unknown), Emil Nielsen Holck, Didier Carrié, Norbert Frey, Matthias Lutz, (unknown), Dariusz Dudek, Bernard Chevalier, Jouke Dijkstra, Jens Flensted Lassen, Jeffrey Anderson, Evald Høj Christiansen, Alexandre Abizaid, Niels Ramsing Holm	1
9	Myocardial Fibrosis in Hypertrophic Cardiomyopathy 2015 ·Journal of Computer Assisted Tomography ·Christoph Langer, Philipp J. Schaefer, Matthias Lutz, Matthias Eden, (unknown), (unknown), Lothar Faber, Olav Jansen, Marcus Both, Norbert Frey	8
10	Service Robot Control Architectures for Flexible and Robust Real-World Task Execution: Best Practices and Patterns. 2014 ·GI-Jahrestagung ·Matthias Lutz, D. Stampfer, (unknown), Christian Schlegel	3
11	Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients 2014 ·International journal of cardiac imaging ·C. Langer, Matthias Lutz, Matthias Eden, (unknown), (unknown), (unknown), Marcus Both, Wolfgang Burchert, Lothar Faber, Dieter Horstkotte, Norbert Frey, Christian Prinz	36
12	Economic Evaluation Of Linezolid Versus Vancomycin For Ventilator-Associated Pneumonia Patients In Guatemala 2013 ·Value in Health ·Matthias Lutz, Rodrigo López, (unknown), Genoveva Cuesta	1
13	Cost-Effectiveness Analysis Of Etanercept Versus Available Anti-Tnf And Il-6 Blockers For Treating Rheumatoid Arthritis In Honduras 2013 ·Value in Health ·Matthias Lutz, (unknown), (unknown), Genoveva Cuesta	0
14	TCT-39 12-Month Angiographic and Clinical Results of the ReZolve(r) Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial 2013 ·Journal of the American College of Cardiology ·Alexandre Abizaid, Johannes Brachmann, J. Ribamar Costa, Dariusz Dudek, Norbert Frey, Matthias Heigert, Matthias Lutz, Axel Schmermund, Jeffrey Anderson	6
15	Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension 2012 ·European Journal of Clinical Investigation ·Mark Rosenberg, F. Joachim Meyer, Ekkehard Gruenig, Matthias Lutz, Dirk Loßnitzer, (unknown), Hugo A. Katus, Norbert Frey	31
16	The L-Arginine–Asymmetric Dimethylarginine Ratio is an Independent Predictor of Mortality in Dilated Cardiomyopathy 2012 ·Journal of Cardiac Failure ·Maike Anderssohn, Mark Rosenberg, Edzard Schwedhelm, Christian Zugck, Matthias Lutz, Nicole Lüneburg, Norbert Frey, Rainer H. Böger	40
17	PIN59 A Cost-Effectiveness Analysis of Voriconazol, Anfotericine B and Caspofungin for Invasive Aspergilosis Patients in Panama 2011 ·Value in Health ·Matthias Lutz, (unknown), Gustavo Morales, Genoveva Cuesta	1
18	FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK 2009 ·Basic Research in Cardiology ·Emmanuel Chorianopoulos, (unknown), Matthias Lutz, Derk Frank, Florian Bea, Hugo A. Katus, Norbert Frey	93
19	Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells 2007 ·Cardiovascular Research ·Matthias Lutz, Mark E. Rosenberg, Fabian Kießling, Volker Eckstein, (unknown), Jutta Krebs, Anthony D. Ho, Hugo A. Katus, Norbert Frey	46
20	Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress 2004 ·Nature Medicine ·Norbert Frey, Tomasa Barrientos, John M. Shelton, Derk Frank, Hartmut Rütten, Doris Gehring, Christian Kühn, Matthias Lutz, Beverly A. Rothermel, Rhonda Bassel‐Duby, James A. Richardson, Hugo A. Katus, Joseph A. Hill, Eric N. Olson	173

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact